Lee, Edwin – Trademark Portfolio

Entity Type: 01

Lee, Edwin holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MAEVN. The owner is based in Irving, TX.

501 Byron Ct.

Irving, TX 75038

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MARYJANE
MARYJANE
Abandoned 2017
MAEVN
MAEVN
Registered 2011
SURGERA
SURGERA
Abandoned 2010
COR
COR
Abandoned 2010
Trademark
Serial #85007500
Registered 2010

Trademark Classifications

Lee, Edwin's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (5 filings)

Clothing, footwear, headgear

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Lee, Edwin have?

Lee, Edwin has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 abandoned.

What trademark classes does Lee, Edwin file in?

Lee, Edwin files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 35 (Advertising & Business), Class 10 (Medical Apparatus). Class 25 covers clothing, footwear, headgear.

What are Lee, Edwin's most well-known trademarks?

Lee, Edwin's registered trademark portfolio includes well-known marks such as MAEVN. These are among 2 currently registered trademarks in the portfolio.

What is Lee, Edwin's trademark registration success rate?

Lee, Edwin has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.